These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30489667)

  • 1. Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma.
    Caponio VCA; Troiano G; Botti G; Pedicillo MC; Lo Russo L; Mastrangelo F; Ciavarella D; Losito NS; Aquino G; Nocini R; Santoro R; Santoro A; Lo Muzio L; Pannone G
    J Oral Pathol Med; 2019 Feb; 48(2):108-114. PubMed ID: 30489667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
    Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
    Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?
    Qiao JJ; Chan TH; Qin YR; Chen L
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):865-8. PubMed ID: 24928581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
    de Santiago PR; Blanco A; Morales F; Marcelain K; Harismendy O; Sjöberg Herrera M; Armisén R
    Life Sci; 2021 Mar; 268():118956. PubMed ID: 33383047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAR1 overexpression is associated with cervical cancer progression and angiogenesis.
    Chen Y; Wang H; Lin W; Shuai P
    Diagn Pathol; 2017 Jan; 12(1):12. PubMed ID: 28109322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.
    Zhang J; Chen Z; Tang Z; Huang J; Hu X; He J
    Tumour Biol; 2017 Jul; 39(7):1010428317708546. PubMed ID: 28714361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
    Zheng J; Wang F; Yang Y; Xu J; Yang J; Wang K; Liu Y; Du G; Zeng Y
    J Oral Pathol Med; 2019 Sep; 48(8):686-695. PubMed ID: 31134698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
    Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
    Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
    Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
    Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
    Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1α-inhibiting factors.
    Ma CP; Liu H; Yi-Feng Chang I; Wang WC; Chen YT; Wu SM; Chen HW; Kuo YP; Shih CT; Li CY; Tan BC
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30948460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
    Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
    Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating Splicing.
    Nakano M; Fukami T; Nakajima M
    J Pharmacol Exp Ther; 2019 Sep; 370(3):408-415. PubMed ID: 31270214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.
    Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC
    Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
    Song IH; Kim YA; Heo SH; Park IA; Lee M; Bang WS; Park HS; Gong G; Lee HJ
    Tumour Biol; 2017 Oct; 39(10):1010428317734816. PubMed ID: 29022489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.